{"id":173754,"date":"2026-02-24T05:16:21","date_gmt":"2026-02-24T05:16:21","guid":{"rendered":"https:\/\/www.europesays.com\/se\/173754\/"},"modified":"2026-02-24T05:16:21","modified_gmt":"2026-02-24T05:16:21","slug":"novo-nordisks-jamforelse-skjuter-ner-egna-lakemedlet","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/173754\/","title":{"rendered":"Novo Nordisks j\u00e4mf\u00f6relse skjuter ner egna l\u00e4kemedlet"},"content":{"rendered":"<p>Novo Nordisks j\u00e4mf\u00f6rande fetmastudie med l\u00e4kemedlet Cagrisema uppn\u00e5dde inte m\u00e5len, skriver bolaget i ett pressmeddelande. <\/p>\n<p>D\u00e4rmed ser man sig slagna av den amerikanska konkurrenten Eli Lilly och deras motsvarighet Zepbound. <\/p>\n<p>Novo Nordisk rasade 16,5 procent p\u00e5 K\u00f6penhamnsb\u00f6rsen. Det \u00e4r den l\u00e4gsta niv\u00e5n sedan juli 2021, skriver DI. <\/p>\n<p>\u201dNovo Nordisk f\u00e5r \u00e5terigen se sig som den mindre akt\u00f6ren i direkt duell med Eli Lilly\u201d, skriver danska B\u00f8rsen. <\/p>\n<p>Omni \u00e4r politiskt obundna och oberoende. Vi str\u00e4var efter att ge fler perspektiv p\u00e5 nyheterna. Har du fr\u00e5gor eller synpunkter kring v\u00e5r rapportering? <a href=\"https:\/\/omni.se\/novo-nordisk-rasar-efter-missat-mal\/a\/mailto:redaktion@omni.se\" class=\"ArticleActions_contactLink__W2F1M\" rel=\"nofollow noopener\" target=\"_blank\">Kontakta redaktionen<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Novo Nordisks j\u00e4mf\u00f6rande fetmastudie med l\u00e4kemedlet Cagrisema uppn\u00e5dde inte m\u00e5len, skriver bolaget i ett pressmeddelande. D\u00e4rmed ser man&hellip;\n","protected":false},"author":2,"featured_media":173755,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[65],"tags":[72,70,71,6631,15365,1206,34,31,33,32,30],"class_list":["post-173754","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ekonomi","tag-business","tag-economy","tag-ekonomi","tag-eli-lilly","tag-kopenhamnsborsen","tag-novo-nordisk","tag-se","tag-svenska","tag-sverige","tag-sweden","tag-swedish"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/116123912393966461","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/173754","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=173754"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/173754\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/173755"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=173754"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=173754"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=173754"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}